Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
Hong Jin(University of Leicester), Xiaofeng Jiang(Shanghai Innovative Research Center of Traditional Chinese Medicine)
Cited by 41
Related Papers
Formation of tissue factor–factor VIIa–factor Xa complex promotes cellular signaling and migration of human breast cancer cells
|Journal of Thrombosis and Haemostasis|2004|104
Cryptopleurine Targets NF-κB Pathway, Leading to Inhibition of Gene Products Associated with Cell Survival, Proliferation, Invasion, and Angiogenesis
|PLoS ONE|2012|50
miR‑204 inhibits the osteogenic differentiation of mesenchymal stem cells by targeting bone morphogenetic protein 2
|Molecular Medicine Reports|2019|19